← Back to companies
Stablix
0 open
New York, New York, United StatesFounded 202123+ employeesSeries A raisedSeries APrivate
Last round: series a · $63M · Jun 2021(1 rounds total)
Founded by Brian Bowman, Carlo Rizzuto, Henry Colecraft, Kevin Sprott, Scott Kanner
Backed by(5 investors)
Versant VenturesEuclidean CapitalAlexandria Real Estate EquitiesCormorant Asset ManagementNew Enterprise Associates
Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. Co-located in New York City and Boston, we are a creative and multidisciplinary team of scientists, innovators and leaders dedicated to changing the way we approach drug development by establishing a powerful small-molecule modality for a wide variety of devastating diseases.
Open Positions at Stablix (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Stablix?
